Proliferative markers, such as Ki‐67, PCNA, PHH3, and Cyclin D1, have been investigated for their potential use as predictive and prognostic biomarkers in pancreatic cancer chemotherapy. The gene discussed is MKI67; the disease is familial pancreatic carcinoma.